By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
No open-market selling at GE HealthCare Technologies Inc. in the past year, which is unusual. Instead eight company insiders purchased about $6.4 million worth of GEHC.
Biggest single buyer: CULP H LAWRENCE JR, Director, with roughly $5 million. Notably, at least one C-suite executive was among the buyers.
GEHC also shows up in congressional disclosures: 7 reported trades from five lawmakers in two years. Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters. 1,224 investment managers listed GEHC in their latest 13F filings (Q2 2026); more funds sold than bought.
Are insiders buying or selling GEHC stock?
In the last 12 months GE HealthCare Technologies Inc. insiders made open-market purchases worth about $6.4 million and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in GEHC?
The most recent open-market insider trade in GEHC was filed on 2026-05-26.
How many institutions own GEHC?
1,224 investment managers reported holding GEHC in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded GEHC?
Yes. Members of Congress reported 7 trades in GEHC over the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).